Inspira Technologies Explores Artificial Womb Use for ART100 Device
Ticker: IINNW · Form: 6-K · Filed: Apr 3, 2024 · CIK: 1837493
| Field | Detail |
|---|---|
| Company | Inspira Technologies Oxy B.H.N. LTD (IINNW) |
| Form Type | 6-K |
| Filed Date | Apr 3, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: medical-device, research-and-development, new-application
TL;DR
Inspira exploring ART100 for artificial womb tech - big potential if it works.
AI Summary
On April 3, 2024, Inspira Technologies Oxy B.H.N. Ltd. announced a program to explore the use of its INSPIRA ART100 device for an artificial womb. This initiative aims to pioneer the applicable use of the device in this novel application.
Why It Matters
This development could represent a significant advancement in reproductive technology and fetal development research if successful.
Risk Assessment
Risk Level: medium — The success of pioneering a new application like an artificial womb is inherently uncertain and carries significant research and development risks.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant announcing the program
- INSPIRA ART100 (product) — Device being explored for artificial womb application
FAQ
What is the specific goal of the program announced by Inspira Technologies?
The program aims to pioneer the applicable use of the INSPIRA ART100 device for an artificial womb.
When was this program announced?
The program was announced on April 3, 2024.
What is the name of the device Inspira Technologies is focusing on?
The device is named INSPIRA ART100.
What type of filing is this report?
This is a Form 6-K report of foreign private issuer.
What is the company's principal executive office address?
The address is 2 Ha-Tidhar St. Ra'anana 4366504, Israel.
Filing Stats: 307 words · 1 min read · ~1 pages · Grade level 8.7 · Accepted 2024-04-03 08:56:49
Filing Documents
- ea0203238-6k_inspira.htm (6-K) — 11KB
- ea020323801ex99-1_inspira.htm (EX-99.1) — 7KB
- 0001213900-24-029603.txt ( ) — 20KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: April 3, 2024 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2